- Presentations
- 2
- Markets
- 1
Filspari is a brand of Sparsentan marketed by Travere Therapeutics, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Sparsentan
- Brand owner
- Travere Therapeutics
- Registered in
- United States
- Strengths and forms
- 200 mg tablet, 400 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Filspari 200 mg tabletOral | Travere Therapeutics | US FDA | Available on request |
| Filspari 400 mg tabletOral | Travere Therapeutics | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Filspari
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.